Narrow search
Showing 1 - 10 of 107
Cover Image
The design and development of a personalized medicine support system
Iannotti, Nicholas V - 2009
The use of a patient's genetic data to aid clinical diagnosis and drug treatment represents a major milestone in the contribution of genomic research to healthcare practices. Initial implementation of a personalized medicine system is currently possible, uniting the areas of medicine, genomics,...
Persistent link: https://www.econbiz.de/10009430566
Cover Image
Assessing Quality Improvement Infrastructure in the Formation of Accountable Care Organizations: A Regional Policy Analysis for the Pharmaceutical Industry
Carr-Whealy, Nathan - 2011
Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...
Persistent link: https://www.econbiz.de/10009434765
Cover Image
Valuing Water - A Globally Sustainable Approach for the Pharmaceutical Industry
Donnelly, Kristina; Dorau, Therese; Koslow, Melinda; … - 2008
Water resources around the globe are at risk from expanding demand and decreasedavailability. All sectors of society rely on water for operation – agriculture, industry, powergeneration, and domestic users all require a constant, clean supply. As a result of populationgrowth and environmental...
Persistent link: https://www.econbiz.de/10009476746
Cover Image
Novartis and the United Nations Global Compact Initiative
Tavis, Lee A. - 2002
The spirit of the Global Compact found fertile ground and has become an integral part of Novartis corporate strategy since the enterprise was formed by the merger of the two large Swiss pharmaceutical companies, Sandoz and Ciba, in 1996. Following a four-year concentration on economic...
Persistent link: https://www.econbiz.de/10009476845
Cover Image
Agency Influences on Risk Reduction and Operating Performance: An Empirical Investigation Among Strategic Groups
Veliyath, Rajaram; Ferris, Stephen P. - 1997
The relationships between risk and performance were tested employing within and between analyses at the level of strategic groups in three different industries. As hypothesized, systematic risk did not exhibit a consistent relationship with performance. By contrast, all of the total...
Persistent link: https://www.econbiz.de/10009459032
Cover Image
Making connections: the importance of human relationships in innovative practice
Bruce, Fraser; Baxter, Seaton - 2008
For many years, the pharmaceutical industry has been one of the leaders in innovation through R&D and its impact has … parent company are concerned separately with the development of pharmaceuticals (or drugs) and a wide range of new drug … problem-solving and reflects on their likely impact on product innovation. It suggests a number of specific outcomes for the …
Persistent link: https://www.econbiz.de/10009463504
Cover Image
Dr. Peter F. Drucker on business & management, tape 2
Drucker, Peter F. (Peter Ferdinand) - 1994
During Peter Drucker’s talk entitled "From Computer Literacy to Information Literacy" he discusses information systems and how they impact individual enterprises and workers. During his lecture, he talks about: the changing labor force, organization structure, command and control structure,...
Persistent link: https://www.econbiz.de/10009429630
Cover Image
Change agents and the evolution of the United States pharmaceutical industry, 1920--1960
Lee, Jeho - 1996
This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...
Persistent link: https://www.econbiz.de/10009439017
Cover Image
"Your Life is Waiting!": Symbolic Meanings in Direct-to-Consumer Antidepressant Advertising
Grow, Jean; Park, Jin Seong; Han, Xiaoqi - 2006
This semiotic analysis demonstrates how pharmaceutical companies strategically frame depression within the hotly contested terrain of direct-to-consumer (DTC) advertising. The study tracks regulation of the pharmaceutical industry, relative to DTC advertising, including recent industry codes of...
Persistent link: https://www.econbiz.de/10009484498
Cover Image
Consumer construction of the agricultural biotechnology industry's legitimacy: An empirical test of values congruency as institutional and actional legitimacy formation
Mosley, Raul A - 2006
institutional legitimacy) and to market drug-producing crops called Plant Made Pharmaceuticals (an instance of actional legitimacy …. Consumers were more slightly more likely to acknowledge the industry's right to market Plant Made Pharmaceuticals (r = .257 … as a big business entity and to market Plant Made Pharmaceuticals. …
Persistent link: https://www.econbiz.de/10009430368